LEXEO THERAPEUTICS, INC.
LEXEO THERAPEUTICS, INC. is a registered legal entity registered in United States under 6236822, and its current status with New York Department of State — Division of Corporations is active. The company was incorporated on 4 August 2021 and lists its registered address as New York, United States. 2 shareholders are on record for LEXEO THERAPEUTICS, INC., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from New York Department of State — Division of Corporations and was last updated on 21 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
2
Two shareholders are currently on record for LEXEO THERAPEUTICS, INC., reflecting the stock ledger kept by the company under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.
The largest of these is Vanguard Group Inc, holding 8.9% — the largest recorded stake — followed by Fidelity Salem Street Trust-Fidelity Small Cap Index Fund at 0.6%.
Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Vanguard Group Inc | 8.9% | New York Department of State — Division of Corporations | |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 0.6% | New York Department of State — Division of Corporations |
Officers
5
The Chairman of LEXEO THERAPEUTICS, INC. currently on record is STEVEN ALTSCHULER; five officers are currently on record for LEXEO THERAPEUTICS, INC., filed with New York Department of State — Division of Corporations.
The register reports 18 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at LEXEO THERAPEUTICS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns LEXEO THERAPEUTICS, INC.?
Two shareholders are currently on record for LEXEO THERAPEUTICS, INC., reflecting the stock ledger kept by the company under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Vanguard Group Inc, holding 8.9% — the largest recorded stake — followed by Fidelity Salem Street Trust-Fidelity Small Cap Index Fund at 0.6%. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is LEXEO THERAPEUTICS, INC.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for LEXEO THERAPEUTICS, INC. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does LEXEO THERAPEUTICS, INC. have on record?
2 shareholders are shown on record for LEXEO THERAPEUTICS, INC..
What is LEXEO THERAPEUTICS, INC.'s company registration number?
LEXEO THERAPEUTICS, INC.'s registration number is 6236822, filed with New York Department of State — Division of Corporations in United States. Its current status on the register is active.
Is LEXEO THERAPEUTICS, INC. still an active company?
LEXEO THERAPEUTICS, INC.'s status on New York Department of State — Division of Corporations is listed as active.
When was LEXEO THERAPEUTICS, INC. incorporated?
LEXEO THERAPEUTICS, INC. was incorporated on 4 August 2021, according to New York Department of State — Division of Corporations.
What is LEXEO THERAPEUTICS, INC.'s registered address?
The registered address on file for LEXEO THERAPEUTICS, INC. is New York, United States.
Who are the officers/directors of LEXEO THERAPEUTICS, INC.?
The Chairman of LEXEO THERAPEUTICS, INC. currently on record is STEVEN ALTSCHULER; five officers are currently on record for LEXEO THERAPEUTICS, INC., filed with New York Department of State — Division of Corporations. Management authority at LEXEO THERAPEUTICS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Can Zavia monitor changes to LEXEO THERAPEUTICS, INC.'s ownership over time?
This profile reflects a point-in-time snapshot from New York Department of State — Division of Corporations. Zavia's monitoring API can track changes to LEXEO THERAPEUTICS, INC.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access LEXEO THERAPEUTICS, INC.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like LEXEO THERAPEUTICS, INC.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from New York Department of State — Division of Corporations and was last synced on 21 October 2026.